Valuation: Lead Data Inc.

Market Cap 539M 16.55M 14.74M 13.64M 12.36M 23.2M 1.57B 23.54M 164M 64.81M 823M 62.11M 60.78M 2.6B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.44M 15.53M 14.38M 13.03M 24.46M 1.66B 24.81M 173M 68.32M 867M 65.47M 64.07M 2.74B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 2022-08-16
Director of Finance/CFO - 2022-06-09
Corporate Officer/Principal - 2022-06-09
Director TitleAgeSince
Director/Board Member - 2019-06-09
Chairman - 2022-08-16
Director/Board Member - 2022-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+31.73% 16.53M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.16%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average -1.27%+1.09%-7.59%+24.24% 75.84B
Weighted average by Cap. -0.01%+3.09%-11.77%+21.99%

Financials

2024 2025
Net sales 15.47M 475K 423K 392K 355K 666K 45.1M 676K 4.71M 1.86M 23.63M 1.78M 1.74M 74.59M 111M 3.4M 3.03M 2.8M 2.54M 4.77M 323M 4.84M 33.67M 13.32M 169M 12.76M 12.49M 534M
Net income -134M -4.11M -3.66M -3.39M -3.07M -5.76M -390M -5.85M -40.7M -16.1M -204M -15.42M -15.09M -645M -44.02M -1.35M -1.2M -1.11M -1.01M -1.9M -128M -1.92M -13.39M -5.3M -67.24M -5.08M -4.97M -212M
Net Debt -16.95M -521K -464K -429K -389K -730K -49.44M -741K -5.16M -2.04M -25.9M -1.95M -1.91M -81.76M 29.12M 895K 796K 737K 668K 1.25M 84.92M 1.27M 8.86M 3.5M 44.48M 3.36M 3.29M 140M
Projected Income Statement - Annual - Lead Data Inc.
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock